Wealth Manager - the site for professional investment managers

Register to get unlimited access to Citywire’s fund manager database. Registration is free and only takes a minute.

JP Morgan boss Dimon diagnosed with throat cancer

JP Morgan chairman and CEO Jamie Dimon has revealed that he is suffering from throat cancer although it is said to be 'curable'.

Dimon's condition was revealed to staff through an internal memo with Dimon saying he will work through his treatment and that he plans to be at the bank for at least five years.

His openness won praise from Warren Buffett, who said Dimon got it 'just right' according to the FT. Buffet revealed that he had prostate cancer back in 2012, while Intel boss Andy Grove was also diagnosed while in the job.

Despite the potential problems of having a sick CEO at the helm, research by the Washington Post shows that Buffett and Grove's announcements barely moved their companies' share prices. Although Apple share price did get affected by news around former CEO Steve Job's health, it actually rose when he died in 2011.  

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.
Citywire TV
Play Biotech Growth: we will ride out this storm

Biotech Growth: we will ride out this storm

Geoffrey Hsu of Biotech Growth Trust says the sell-off in biotechnology stocks represents a buying opportunity for long-term investors.

Play Picton: the UK property hotspots for rental income

Picton: the UK property hotspots for rental income

Picton Property Income CEO Michael Morris reveals how he is planning to ride the ‘ripple effect’ as UK economic growth spills out from the capital across the country.

Brewin's Foster talks financial crisis MkII with Allianz's Riddell

Brewin's Foster talks financial crisis MkII with Allianz's Riddell

This week Brewin Dolphin's head of research talks to Mike Riddell, fund manager at Allianz Global Investors, about the forces driving bonds markets in a tumultuous week for markets.

Your Business: Cover Star Club

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

Profile: PortfolioMetrix is on a mission to kill 'Frankenstein' systems

In a buyers’ market for off-the-peg discretionary management, self-funded start-ups begin at an inherent disadvantage

Wealth Manager on Twitter